Abstract
Cancer is one of the most prolific causes of death all around the world. Currently there is a huge focus around the globe on the identification of effective drugs against this disease. One important target is the development of new anti-angiogenic compounds. Fumagillin and other structurally related molecules are some of the most potent anti-angiogenic compounds reported to date with several currently being investigated in clinical studies.
Fumagillin has been used for more than 50 years against microsporidial parasites in animals, however, angiogenesis inhibition constitutes a new activity and an important research topic, this is the reason why nowadays some teams are working to achieve an effective way to obtain fumagillin analogues with more potent anti-angiogenic activity.
Here we present an overview on fumagillin and fumagillin analogues as leads products; we summarize the key structural features for antiangiogenic activity and discuss the total synthesis and synthesis of analogues and their biological activity.
Keywords: Angiogenesis, anti-angiogenic therapy, fumagillin, ovalicin, structure-activity relationship, TNP470, Nosema Apis, Nosema Ceranae, AGM-1470, Plasmodium falciparum, Pollini, Sorensen
Mini-Reviews in Organic Chemistry
Title:Fumagillin and Structurally Related Molecules as Source of New Drugs
Volume: 9 Issue: 2
Author(s): Diego Gamba-Sanchez
Affiliation:
Keywords: Angiogenesis, anti-angiogenic therapy, fumagillin, ovalicin, structure-activity relationship, TNP470, Nosema Apis, Nosema Ceranae, AGM-1470, Plasmodium falciparum, Pollini, Sorensen
Abstract: Cancer is one of the most prolific causes of death all around the world. Currently there is a huge focus around the globe on the identification of effective drugs against this disease. One important target is the development of new anti-angiogenic compounds. Fumagillin and other structurally related molecules are some of the most potent anti-angiogenic compounds reported to date with several currently being investigated in clinical studies.
Fumagillin has been used for more than 50 years against microsporidial parasites in animals, however, angiogenesis inhibition constitutes a new activity and an important research topic, this is the reason why nowadays some teams are working to achieve an effective way to obtain fumagillin analogues with more potent anti-angiogenic activity.
Here we present an overview on fumagillin and fumagillin analogues as leads products; we summarize the key structural features for antiangiogenic activity and discuss the total synthesis and synthesis of analogues and their biological activity.
Export Options
About this article
Cite this article as:
Gamba-Sanchez Diego, Fumagillin and Structurally Related Molecules as Source of New Drugs, Mini-Reviews in Organic Chemistry 2012; 9 (2) . https://dx.doi.org/10.2174/157019312800604724
DOI https://dx.doi.org/10.2174/157019312800604724 |
Print ISSN 1570-193X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6298 |
Call for Papers in Thematic Issues
Applications of Molecular Descriptors in Physicochemical Properties Research of Organic Compounds
Chemical graph theory is concerned with all aspects of the application of graph theory to various areas of chemistry, including organic, theoretical, mathematical, and computational chemistry, as well as in bioinformatics and computational biology. By the use of the term chemical it is emphasized that one is allowed in chemical ...read more
Navigating the 2D Universe in Organic Chemistry
This special issue explores the transformative impact of two-dimensional (2D) materials on the realm of organic chemistry, unraveling new possibilities for synthesis, functionalization, and applications of organic compounds. Focused on the unique chemistry within this novel dimension, the issue highlights breakthroughs in the field of 2D organic chemistry. Contributions are ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
LHON: Mitochondrial Mutations and More
Current Genomics Vascular Endothelial Growth Factor (VEGF) as a Target of Bevacizumab in Cancer: From the Biology to the Clinic
Current Medicinal Chemistry BM 212 and its Derivatives as a New Class of Antimycobacterial Active Agents
Current Medicinal Chemistry MYC as Therapeutic Target for Embryonal Tumors: Potential and Challenges
Current Cancer Drug Targets Anaplastic Lymphoma Kinase Inhibitors in Non-Small Cell Lung Cancer
Current Drug Targets Jun Dimerization Protein 2 in Oxygen Restriction; Control of Senescence
Current Pharmaceutical Design Computational Approaches for Predicting Causal Missense Mutations in Cancer Genome Projects
Current Bioinformatics Overcoming the Drug Resistance Problem with Second-Generation Tyrosine Kinase Inhibitors: From Enzymology to Structural Models
Current Medicinal Chemistry ChemoImmunoModulation: Immune Regulation by the Antineoplastic Chemotherapeutic Agents
Current Medicinal Chemistry Inhibition of Multidrug Resistance of Cancer Cells by Natural Diterpenes, Triterpenes and Carotenoids
Current Pharmaceutical Design NFκB Pathway and microRNA-9 and -21 are Involved in Sensitivity to the Pterocarpanquinone LQB-118 in Different CML Cell Lines
Anti-Cancer Agents in Medicinal Chemistry Isolation of Antibodies From Non-Human Primates for Clinical Use
Current Drug Discovery Technologies New Developments In Treatment After Lung Transplantation
Current Pharmaceutical Design Gamma Secretase Inhibitor: Therapeutic Target via NOTCH Signaling in T Cell Acute Lymphoblastic Leukemia
Current Drug Targets Megaspinoxide A: New Norterpene Cyclic Peroxide from the Sponge Diacarnus megaspinorhabdosa
The Natural Products Journal Lipid-Based Drug Delivery Systems for Cancer Treatment
Current Drug Targets Methods of Screening-Purification and Antimicrobial Potentialities of Bacteriocin in Health Care
Current Drug Metabolism Sphingolipids as Emerging Drug Targets: Therapeutic Applications of Ceramide Analogs
Drug Design Reviews - Online (Discontinued) SRLVs: A Genetic Continuum of Lentiviral Species in Sheep and Goats with Cumulative Evidence of Cross Species Transmission
Current HIV Research Protective Effects of Low Dose Vorinostat on Cisplatin-Induced Nephrotoxicity in Rats
Current Molecular Pharmacology